Finalized Preclinical Gene/Cellular Therapy Guidance Skips Sponsor Suggestions

Drug Industry Daily
A A
Finalized guidance on preclinical considerations for gene and cellular therapies, posted Monday, reiterates the agency’s position that sponsors should focus on five objectives in preclinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily